Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib in Neoadjuvant Locally Advanced Thyroid Cancer
NCT04309136Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jun 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in thyroid cancer, sponsored by Fudan University. Status: unknown.
02
Drugs
anlotinib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT04309136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04309136.